Local pharma CEO says Hikma v. Amarin ruling brings clarity, not new opportunities

A recent U.S. Supreme Court ruling could give generic pharmaceutical companies greater protection from patent lawsuits, but Baton Rouge pharmaceutical executive Keith LaNasa says the decision doesn’…